NORTHERN TRUST CORP - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,704,251
-31.4%
4,180,871
+21.6%
0.00%0.0%
Q3 2022$5,398,000
-22.2%
3,437,600
-0.4%
0.00%0.0%
Q2 2022$6,934,000
+5.7%
3,450,139
+22.5%
0.00%0.0%
Q1 2022$6,563,000
-52.1%
2,816,938
-4.4%
0.00%
-50.0%
Q4 2021$13,696,000
-38.5%
2,945,438
+1.0%
0.00%
-50.0%
Q3 2021$22,254,000
-19.6%
2,916,760
+2.2%
0.00%
-20.0%
Q2 2021$27,663,000
+21.7%
2,854,777
+3.9%
0.01%
+25.0%
Q1 2021$22,722,000
+15.0%
2,747,498
-5.1%
0.00%0.0%
Q4 2020$19,765,000
-33.2%
2,895,917
+9.1%
0.00%
-33.3%
Q3 2020$29,604,000
+106.3%
2,655,065
+16.2%
0.01%
+100.0%
Q2 2020$14,353,000
+379.7%
2,285,479
+40.6%
0.00%
+200.0%
Q1 2020$2,992,000
-44.1%
1,625,871
+2.7%
0.00%0.0%
Q4 2019$5,354,000
+67.2%
1,583,872
+5.9%
0.00%0.0%
Q3 2019$3,203,000
-11.2%
1,496,323
+10.7%
0.00%0.0%
Q2 2019$3,607,000
-43.1%
1,351,188
+1.3%
0.00%
-50.0%
Q1 2019$6,337,000
+109.5%
1,333,958
+5.8%
0.00%
+100.0%
Q4 2018$3,025,000
-46.7%
1,260,499
-2.2%
0.00%0.0%
Q3 2018$5,673,000
-21.5%
1,289,486
+28.5%
0.00%
-50.0%
Q2 2018$7,226,000
+798.8%
1,003,650
+542.9%
0.00%
Q1 2018$804,000
+56.7%
156,102
+15.7%
0.00%
Q4 2017$513,000
+72.7%
134,954
-22.6%
0.00%
Q3 2017$297,000
-15.9%
174,327
-1.2%
0.00%
Q2 2017$353,000
-74.3%
176,427
-49.2%
0.00%
Q1 2017$1,372,000
-25.7%
347,311
-7.8%
0.00%
-100.0%
Q4 2016$1,846,000
-36.9%
376,710
-0.3%
0.00%0.0%
Q3 2016$2,925,000
+42.8%
377,904
+3.3%
0.00%0.0%
Q2 2016$2,049,000
+16.4%
365,952
+11.8%
0.00%0.0%
Q1 2016$1,761,000
-37.7%
327,452
+0.9%
0.00%0.0%
Q4 2015$2,826,000
+7.4%
324,398
+3.4%
0.00%0.0%
Q3 2015$2,631,000
+75.0%
313,607
+267.6%
0.00%
Q2 2015$1,503,000
+204.9%
85,317
+100.4%
0.00%
Q1 2015$493,000
+40.9%
42,582
+22.5%
0.00%
Q4 2014$350,000
+104.7%
34,756
-8.0%
0.00%
Q3 2014$171,000
-33.2%
37,774
-0.3%
0.00%
Q2 2014$256,000
+7.6%
37,869
+104.4%
0.00%
Q1 2014$238,00018,5290.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders